Back to Agenda
DIA Startup Accelerator
Session Chair(s)
Falk Ehmann, MD, PHD, MS
Head of Innovation and Development Accelerator, Regulatory Science and Innovation Task Force, European Medicines Agency, Netherlands
Hubert Leufkens, PHARMD, PHD
Emeritus Professor of Pharmaceutical Policy and Regulatory Science, Utrecht University, Netherlands
Rabia Sucu
Senior Technical Advisor, Management Sciences for Health, Ukraine
This session gives innovators the opportunity to learn about pathways to communicate effectively with Regulatory Authorities and HTA bodies and discuss challenges of value and access specific for innovative healthcare products. See real-life examples what happens when HTA and regulatory considerations are tackled later in product development cycle, how those affect market authorization and product acquisition. Create long-lasting relationships with experts who will be able to advise and support you.
13:50 - 14:00: Introduction & Welcome
14:10 - 14:20: The Power of Regulatory and HTA Awareness in the Life of a Startup – my Story
14:20 - 14:30: Introduction to HTA Fundamentals
14:30 - 14:40: Introduction to Regulatory Affairs Opportunities
14:40 - 14:50: Break
14:50 - 15:10: Panel Discussion with Q&A
Speaker(s)
Thomas Broeckhoff, MSC
Project Manager, hollandbio, Netherlands
The Power of Regulatory and HTA Awareness in the Life of a Startup – My Story
Rabia Sucu
Senior Technical Advisor, Management Sciences for Health, Ukraine
Introduction to HTA Fundamentals
Falk Ehmann, MD, PHD, MS
Head of Innovation and Development Accelerator, Regulatory Science and Innovation Task Force, European Medicines Agency, Netherlands
Introduction to Regulatory Affairs Opportunities
Meelis Lootus, PHD, MS, MSC
CEO & Founder, Tehistark, United Kingdom
Have an account?